These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9509054)

  • 1. Amiodarone.
    Swanton H
    Br J Hosp Med; 1997 Oct 1-14; 58(7):329-32. PubMed ID: 9509054
    [No Abstract]   [Full Text] [Related]  

  • 2. Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
    Cawley PJ; Al-Khatib SM
    Am Heart J; 2004 May; 147(5):790-1. PubMed ID: 15131532
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of incessant ventricular tachycardia in a 39-year-old woman with cardiomyopathy.
    Schuster MM
    Am J Crit Care; 1997 Nov; 6(6):467-71. PubMed ID: 9354226
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical utility and adverse effects of amiodarone therapy.
    Roberts M
    AACN Adv Crit Care; 2010; 21(4):333-8; quiz 339-40. PubMed ID: 21045568
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous amiodarone.
    Dimens Crit Care Nurs; 2000; 19(1):29. PubMed ID: 10876483
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodynamics during chronic amiodarone administration in Japanese patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia: a retrospective study.
    Suzuki T; Shiga T; Wakaumi M; Matsuda N; Ishizuka N; Kasanuki H
    J Cardiol; 2003 Apr; 41(4):169-73. PubMed ID: 12728537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone for ventricular tachycardia after coronary artery bypass grafting.
    Terada Y; Mitsui T; Yoshimura Y; Osaka M; Mihara W
    Ann Thorac Surg; 1995 Oct; 60(4):1155. PubMed ID: 7574979
    [No Abstract]   [Full Text] [Related]  

  • 9. Ventricular tachycardia associated with mid-ventricular obstructive hypertrophic cardiomyopathy and apical aneurysm.
    Cannavà G; Currò A
    Int J Cardiol; 2015 Dec; 201():382-3. PubMed ID: 26310983
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiomyopathy induced by incessant ventricular tachycardia ("tachycardiomyopathy"): cure after control of arrhythmia].
    Sternick EB; Bahia FC; Gontijo Filho B; Vrandecic MO
    Arq Bras Cardiol; 1992 Mar; 58(3):209-14. PubMed ID: 1340201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative antiarrhythmic efficacy of amiodarone and dronedarone during acute myocardial infarction in rats.
    Agelaki MG; Pantos C; Korantzopoulos P; Tsalikakis DG; Baltogiannis GG; Fotopoulos A; Kolettis TM
    Eur J Pharmacol; 2007 Jun; 564(1-3):150-7. PubMed ID: 17391666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of amiodarone in the management of patients with cardiac arrest.
    Franks AM; Watterson KS
    J Ark Med Soc; 2000 Dec; 97(6):196-9. PubMed ID: 12876823
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular news. AMIOVIRT.
    SoRelle R
    Circulation; 2000 Dec; 102(25):E9050-1. PubMed ID: 11120713
    [No Abstract]   [Full Text] [Related]  

  • 14. Amiodarone and lipid disorder.
    Ahmad S
    Arch Intern Med; 1995 Sep; 155(17):1912. PubMed ID: 7677559
    [No Abstract]   [Full Text] [Related]  

  • 15. Irregular ventricular tachycardia underdetected by implantable cardioverter defibrillator device.
    Manolis AG; Kourouklis S; Chatzis D; Kouvelas K; Kyriakides Z
    Cardiol J; 2008; 15(3):281-3. PubMed ID: 18651422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperkalemia probably reverses the antiarrhythmic effects of amiodarone: a case report.
    Akiyama J; Tomizawa T; Umezawa S; Morishima A
    Jpn Circ J; 1999 Apr; 63(4):323-5. PubMed ID: 10475784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for ventricular arrhythmias in the era of the implantable cardioverter defibrillator.
    Peters NS
    Eur Heart J; 1999 Mar; 20(5):321-3. PubMed ID: 10206376
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of intravenous agents for ventricular arrhythmias.
    Nolan PE
    Pharmacotherapy; 1997; 17(2 Pt 2):65S-75S; discussion 89S-91S. PubMed ID: 9085342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports].
    Kimura M; Ogawa H; Wakeyama T; Takaki A; Iwami T; Hadano Y; Miyazaki Y; Shimizu A; Matsuzaki M
    J Cardiol; 2006 Dec; 48(6):359-65. PubMed ID: 17243631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of relatively low dose amiodarone therapy on left ventricular function in patients with ventricular tachyarrhythmias.
    Yamada S; Yamaguchi I
    Jpn Circ J; 1998 Sep; 62(9):707-9. PubMed ID: 9766713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.